1-8 of 8
Leylah Drusbosky
Close
Sort by
Journal Articles

CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia

Huacheng Luo, Fei Wang, Jie Zha, Haoli Li, Bowen Yan, Qinghua Du, Fengchun Yang, Amin Sobh, Christopher Vulpe, Leylah Drusbosky, Christopher Cogle, Iouri Chepelev, Bing Xu, Stephen D. Nimer, Jonathan Licht, Yi Qiu, Baoan Chen, Mingjiang Xu, Suming Huang
Journal: Blood
Blood (2018) 132 (8): 837–848.
https://doi.org/10.1182/blood-2017-11-814319
Published: 2018
Includes: Supplemental data
Journal Articles

A Genomic Rule Predicting HMA Treatment Response in MDS Identified By Protein Network Mapping and Validated By Clinical Trial Simulation

Leylah Drusbosky, PhD, Neeraj Kumar Singh, Pranav Tiwari, Shireen Vali, PhD, Taher Abbasi, Sarbjit Sarkaria, Adam Lorant, Satin Burns, Rafael Bejar, MD PhD, Christopher R. Cogle, MD
Journal: Blood
Blood (2016) 128 (22): 3151.
https://doi.org/10.1182/blood.V128.22.3151.3151
Published: 2016
Journal Articles

A Genomic Signature Predicting Venetoclax Treatment Response in AML Identified By Protein Network Mapping and Validated By Ex Vivo Drug Sensitivity Testing: A Beat AML Project Study

Leylah Drusbosky, PhD, Taher Abbasi, Shireen Vali, PhD, Saumya Radhakrishnan, Neeraj Kumar Singh, Shahabuddin Usmani, Deepak Parashar, Robinson Vidva, Brian J. Druker, MD, Cristina E. Tognon, Pierrette Lo, MS, Jeffrey W. Tyner, Christopher R. Cogle, MD
Journal: Blood
Blood (2016) 128 (22): 1713.
https://doi.org/10.1182/blood.V128.22.1713.1713
Published: 2016
Journal Articles

Icare 1: A Prospective Clinical Trial to Predict Treatment Response Based on Mutanome-Informed Computational Biology in Patients with AML and MDS

Leylah Drusbosky, PhD, Elizabeth Wise, BS, Shireen Vali, PhD, Taher Abbasi, Ansu Kumar, Neeraj Kumar Singh, Kabya Basu, Chandan Kumar, Amjad Husain, Fei Zou, PhD, Caitlin Tucker, BS, Randy A Brown, MD, Maxim Norkin, MD PhD, John Hiemenz, MD, John R. Wingard, MD, Jack W Hsu, MD, Christopher R. Cogle, MD
Journal: Blood
Blood (2016) 128 (22): 594.
https://doi.org/10.1182/blood.V128.22.594.594
Published: 2016
Journal Articles

Use of Genomic Information to Predict Treatment Response in Multiple Myeloma Patients By Computational Mapping of Protein Network Disturbances

Leylah Drusbosky, PhD, Mark A Fiala, BS, CCRP, Justin A King, Ravi Vij, MD MBA, Shireen Vali, PhD, Taher Abbasi, Neeraj Kumar Singh, Ansu Kumar, Saji Gera, Christopher R. Cogle, MD
Journal: Blood
Blood (2016) 128 (22): 2099.
https://doi.org/10.1182/blood.V128.22.2099.2099
Published: 2016
Journal Articles

Ex Vivo High-Throughput Flow Cytometry Screening Identifies Subsets of Responders to Differentiation Agents in Individual AML Patient Samples

Sacha L. Prashad, PhD, Leylah Drusbosky, PhD, Hassan Sibai, MD, Mark D. Minden, MD PhD, Stephen J. Western, Chris Biondi, MS, Reecha Shah, MS, Debra Liu, MS, Transon Nguyen, MS, Connor Warnock, BS, Pete Quinzio, BA, Matthew De Silva, BS, Elie Traer, MD, Christopher R. Cogle, MD, Aaron D. Schimmer, MD PhD, Diane Heiser, PhD
Journal: Blood
Blood (2016) 128 (22): 5206.
https://doi.org/10.1182/blood.V128.22.5206.5206
Published: 2016
Journal Articles

Predicting MDS Response to Drug Therapies Based on a New Method of Interpreting the MDS Mutanome

Cindy Medina, B.S., Leylah Drusbosky, BS, Myron Chang, PhD, Shireen Vali, Ansu Kumar, Neeraj Kumar Singh, Taher Abbasi, Mikkael A. Sekeres, MD MS, Mar Mallo, PhD, Francesc Sole, PhD, Rafael Bejar, MDPhD, Christopher R. Cogle, MD
Journal: Blood
Blood (2015) 126 (23): 96.
https://doi.org/10.1182/blood.V126.23.96.96
Published: 2015
Journal Articles

Bone Marrow Endothelial Cells Protect Acute Myeloid Leukemia From Chemotherapy By Direct Contact: The BCAM/Laminin/VLA5 Axis As a Potential Therapeutic Target

Leylah Drusbosky, BS, Amy Meacham, MS, Elizabeth Wise, BS, Edward W Scott, PhD, Christopher R Cogle, MD
Journal: Blood
Blood (2013) 122 (21): 2546.
https://doi.org/10.1182/blood.V122.21.2546.2546
Published: 2013